All treatments
Treatment
DOCETAXEL HOSPIRA 10 mg/mL clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase II randomized trial, non comparative, evaluating chemotherapy associated cisplatin, 5-fluorouracil and docetaxel at adapted doses in patients with locally advanced squamous cell carcinoma
This study looks at different chemotherapy drugs for people with a certain type of head and neck cancer that hasn't spread far. It checks how well a combination of treatments works after 8 weeks and if it helps people live longer and have a better quality of life.
For: locally advanced squamous cell carcinomaFrance - Ongoing, recruitingTherapeutic exploratory (Phase II)
Perioperative Treatment in Resectable Gastric Cancer with Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): A phase II study (GASPAR)
This study is testing a new combination of treatments for stomach cancer that can be removed with surgery. It combines a new drug, spartalizumab, with a standard chemotherapy (FLOT). Researchers want to see if this new combination helps shrink the cancer more before surgery and improves outcomes.
For: Resectable Gastric CancerFrance